Oregon Clinical and Translational Research Institute

$178,776UL1FY2019TRNIH

Oregon Health & Science University, Portland OR

Investigators

David H. Ellisoncontact Cynthia D Morris

Linked publications, trials & patents

Paper 39461425 Paper 39433942 Paper 39383116 Paper 39380062 Paper 39363958 Paper 39348414 Paper 39306060 Paper 39228701 Paper 39207465 Paper 39206568 Paper 39099263 Paper 39063484 Paper 39023443 Paper 39006760 Paper 38978664 Paper 38947087 Paper 38937779 Paper 38920422 Paper 38917576 Paper 38915860 Paper 38895980 Paper 38885336 Paper 38874614 Paper 38862858 Paper 38857785 Paper 38848964 Paper 38838386 Paper 38822387 Paper 38819662 Paper 38819605 Paper 38818718 Paper 38814888 Paper 38772428 Paper 38746290 Paper 38719138 Paper 38696674 Paper 38664925 Paper 38659823 Paper 38582851 Paper 38571248 Paper 38508400 Paper 38499754 Paper 38464102 Paper 38407631 Paper 38384895 Paper 38348959 Paper 38326668 Paper 38318198 Paper 38271209 Paper 38260609 Paper 38227381 Paper 38195931 Paper 38190702 Paper 38190597 Paper 38168232 Paper 38106125 Paper 38021127 Paper 37979410 Paper 37964700 Paper 37952574 Paper 37931890 Paper 37873013 Paper 37868804 Paper 37865053 Paper 37810879 Paper 37804103 Paper 37800475 Paper 37745522 Paper 37742655 Paper 37741761 Paper 37741702 Paper 37729720 Paper 37724052 Paper 37695743 Paper 37694554 Paper 37672869 Paper 37633589 Paper 37632158 Paper 37615834 Paper 37614297 Paper 37600074 Paper 37592821 Paper 37574121 Paper 37564420 Paper 37543080 Paper 37543077 Paper 37539477 Paper 37534853 Paper 37506692 Paper 37502976 Paper 37501755 Paper 37488533 Paper 37476995 Paper 37436961 Paper 37419144 Paper 37418748 Paper 37405891 Paper 37337303 Paper 37314282 Trial NCT04539002

Abstract

Project Summary Dr. Gourdine is an Afro-Caribbean and a naturalized citizen of the United States. After a first post-doctoral training in France, and a second in the US, he currently holds a position as a Senior Research Associate in the Oregon Clinical & Translational Research Institute (OCTRI) at Oregon Health & Science University (OHSU), in Portland, OR. The diversity supplement proposal in the CTSA hub environment will provide him a quality framework in clinical bioinformatics research. This experience will help him acquire a unique set of skills in a team-science setting and fill the gap of diversity in research at OHSU and nationwide. The central hypothesis is that the analysis of metabolites, glycans, and microbiome and their integration with genomics data can: 1) reveal new biomarkers for known diseases; 2) help diagnose rare genetic diseases; and 3) help the selection of interventions that might lessen disease symptoms or make other treatments more effective. The proposal is an integrative approach to enhance disease comparisons and diagnostics with glycomics and metabolomics, using relevant knowledge-bases, raw data from the Undiagnosed Diseases Network (UDN) patients and the Human Phenotype Ontology (HPO) with the following overall aims: Aim 1. Complete missing metabolomics and glycomics information to improve diagnostic use. Aim 2. Evaluate integration of molecular phenotypes in the diagnostic tools by analyzing undiagnosed patient data.

View original record on NIH RePORTER →